Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Inflammation
Published in: Inflammation 2/2004

01-04-2004

Increased Hepatic Cholesterol Accumulation in Transgenic Mice Overexpressing Human Secretory Phospholipase A2 Group IIA

Authors: Rolf Eckey, Mario Menschikowski, Peter Lattke, Werner Jaross

Published in: Inflammation | Issue 2/2004

Login to get access
Metadata
Title
Increased Hepatic Cholesterol Accumulation in Transgenic Mice Overexpressing Human Secretory Phospholipase A2 Group IIA
Authors
Rolf Eckey
Mario Menschikowski
Peter Lattke
Werner Jaross
Publication date
01-04-2004
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Inflammation / Issue 2/2004
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1023/B:IFLA.0000033021.44105.9c

Other articles of this Issue 2/2004

Inflammation 2/2004 Go to the issue

OriginalPaper

Study on Myeloperoxidase Role in Antituberculous Defense in the Context of Cytokine Activation

OriginalPaper

Effect of Ozone Exposure on Intracellular Glutathione Redox State in Cultured Human Airway Epithelial Cells

OriginalPaper

Induction of Microsomal Prostaglandin E Synthase-1 in Human Gingival Fibroblasts

OriginalPaper

In Vivo Effect of Wood Smoke on the Expression of Two Mucin Genes in Rat Airways

OriginalPaper

A 771726, the Active Metabolite of Leflunomide, Inhibits TNF-α and IL-1 from Kupffer Cells

OriginalPaper

Modulation of Cytokine-Induced Production of IL-8 in Vitro by Interferons and Glucocorticosteroids
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits